When evaluating side effects, the following frequencies are used as a basis: Very common: more than 1 in 10 people Common: less than 1 in 10, but more than 1 in 100 patients Uncommon: less than 1 in 100, but more than 1 in 1000 patients Rare: less than 1 in 1,000 but more than 1 in 10,000 patients Very rare: less than 1 in 10,000 patients treated, or unknown
Sleep pattern disruptions and vivid dreams are occasionally reported
The history of KPV is closely tied to the study of the alpha-melanocyte-stimulating hormone (-MSH), a peptide hormone known for its role in pigmentation, inflammation, and immune modulation
Elevated B12 is well recognized across liver conditions, including alcohol-associated and other chronic liver disease
It works best when it is supported by contextual links and category-level relevance